Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study

• Conditions: Cardiovascular Disease; Psoriasis

• Registration Number: NCT01382784
• Lead Sponsor: Oslo University Hospital

Brief Summary

There is growing evidence that psoriasis is a systemic disorder which enhances atherosclerosis and the risk of cardiovascular disease. Epidemiological studies have shown an independent association between psoriasis and atherosclerosis, stroke and coronary artery disease. The main goal of this on-going study is to register data which will enable the identification of new markers of atherosclerosis activity and carotid plaque instability in patients with severe psoriasis.

Detailed Description

Not available

Study Timeline

• Status Verified: 2011-05
• Study Start: 2011-05
• Study First Submitted: 2011-06-24
• Study First Submitted QC: 2011-06-24
• Last Update Submitted: 2011-06-24
• Study First Posted: 2011-06-27
• Last Update Posted: 2011-06-27

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• >18 years old, psoriasis for more than 5 years, moderate to severe psoriasis (PASI >10 or systemic treatment)

Exclusion Criteria

• familiar hypercholesterolemia, ongoing infections and cancer disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (2)

Oslo university Hospital, Dermatological dept; 🇳🇴 Oslo, Norway

Dermatological Department, OUS; 🇳🇴 Oslo, Norway